Boston Scientific’s Promising Trial Outcomes and Market Expansion Drive Buy Rating
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...
Boston Scientific reaches preliminary settlement
Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...